Brief Title
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
Official Title
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. The Haemo-Adhaesione Questionnaire
Brief Summary
Research project for the development, construction and validation of a questionnaire of adherence to treatment in adult patients with hemophilia. It aims to build a scale according to five relevant dimensions of adherence to treatment: 1) physician-patient relationship, 2) knowledge of the disease, 3) previous bleeding problems, 4) knowledge of future consequences and difficulties, and 5) benefits of treatment.
Detailed Description
- Descriptive study for the construction of a multidimensional scale of adherence to treatment in adult patients with hemophilia. - Validation of a scale specific measure for patients with hemophilia that includes 5 dimensions that may affect adherence to treatment: a) the doctor-patient, b) regarding knowledge of the disease, c) the previous hemorrhages, d) knowledge future sequels, e) difficulties with treatment. - Statistical and psychometric analysis of the adherence questionnaire for adult patients with hemophilia. - Description of the theoretical framework that justifies the completion of the questionnaire, and the choice of the dimensions and items that make up the measurement scale. - The questionnaire obtained in this project will identify the actual degree of patient adherence to multidisciplinary treatment, taking as gold standard, compliance with pharmacological treatment (the difference between the treatment prescribed and consumed).
Study Type
Observational [Patient Registry]
Primary Outcome
Phase substantive for the creation of a scale
Condition
Haemophilia
Study Arms / Comparison Groups
Validation group
Description: Group of patients who we will consult the characteristics of the scale designed and will be made the statistical calculations of validity, reliability and reproducibility
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
100
Start Date
September 2015
Completion Date
May 2016
Primary Completion Date
January 2016
Eligibility Criteria
Inclusion Criteria: - Patients diagnosed with hemophilia A or B. - Patients over 18 years of age. Exclusion Criteria: - Patients with neurological or cognitive impairments that hinder oral and written comprehension. - Patients who have not signed the informed consent document
Gender
Male
Ages
18 Years - 65 Years
Accepts Healthy Volunteers
No
Contacts
Rubén Cuesta-Barriuso, PhD, 868887170, [email protected]
Location Countries
Spain
Location Countries
Spain
Administrative Informations
NCT ID
NCT02197611
Organization ID
Haemo Adhaesione
Secondary IDs
Haemo-Adhaesione
Responsible Party
Principal Investigator
Study Sponsor
Universidad de Murcia
Study Sponsor
Rubén Cuesta-Barriuso, PhD, Principal Investigator, Universidad Católica San Antonio
Verification Date
September 2015